JPRN-UMIN000029739已完成未知
Impact of switching from once-weekly GLP1receptor agonist to once-weekly DPP4inhibitor(Omaligliptin)therapy on glycemic control parameters in type 2 diabetes patients undergoing hemodialysis. - DO study
Minamiosaka hospital0 个研究点目标入组 0 人开始时间: 2017年10月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
o implementation
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Using other GLP1 analog formulation 2.Using other DPP4 inhibitor 3.Hypersensitivity for Dulaglutide and Omarigliptin 4.Severe ketosis,Diabetic coma and pre-coma,type 1 diabetes 5.Severe infection,pre and post operation ,severe trauma,such state with necessity of blood suger management by Insulin treatment 6.Pregnant woman,woman suspected of being pregnant,woman in breast-feeding 7.Patiants recognized to be inappropriate for study by medical basis of doctor
研究者
相似试验
进行中（未招募）
不适用
Effects of once-daily administered GLP-1 Receptoragonist Lixisenatide in combination with basal Insulin on glycemic control in patients with type-2 diabetes mellitus not achieving therapeutic targets with premixed insulin strategy10 patients (both gender) under treatment with premixed insulin (2-3 injections) and HbA1c>7% will be switched to basal insulin glargine (Lantus, once daily) and GLP-1 receptor agonist Lixisenatide (Lyxumia, once daily).EUCTR2013-005334-37-ATMedical University of Vienna / Medizinische Universität Wien
招募中
1 期
TOLEDDO: Effect of weekly GLP1 agonist treatment in double diabetes: a randomized, open-label studyCTIS2024-514906-30-00Centre Hospitalier Universitaire De Dijon76
已完成
不适用
Match-up of two once weekly GLP-1 receptor agonists (exenatide,dulaglutide) about efficacy and satisfactiotype 2 diabetesJPRN-UMIN000023394Tokyo Medical University50
招募中
不适用
Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring.Type 2 diabetesJPRN-UMIN000017144Department of Endocrinology and Metabolism, Dokkyo Medical University30
已完成
不适用
The examination of effects of switching to GLP-1 analog liraglutide or adding on insulin glargine once daily for type 2 diabetes controlled insufficiently by DPP-4 inhibitors and other oral anti-diabetic agents combination (multicenter study).type 2 diabetes mellitusJPRN-UMIN000012224Toho University School of Medicine, Division of diabetes, metabolism and endocrinology60